Neurocrine Biosciences, Inc <NBIX.O>: Guggenheim raises target price to $200 from $175
NBIX•Related News
CBL Properties schedules second-quarter earnings release
CBL•
Equifax posts investor presentation highlighting 2Q earnings review and updated 2026 guidance
EFX•
Nuburu shares trade on OTC Pink as NYSE American listing remains suspended
BURU•
Gold miners climb as bullion prices edge higher
GDX•
Flag Ship Acquisition switches auditor to Wei, Wei & Co. from MaloneBailey
FSHP•